Luye Pharma Group Ltd
HKEX:2186
Luye Pharma Group Ltd
HKEX:2186
Price:
2.75
HKD
1.85%
Market Closed
Market Cap:
HK$11B
Relative Value
The Relative Value of one
Luye Pharma Group Ltd
stock under the Base Case scenario is
hidden
HKD.
Compared to the current market price of 2.75 HKD,
Luye Pharma Group Ltd
is
hidden
.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
Luye Pharma Group Ltd Relative Value
HIDDEN
Multiples Across Competitors
Competitors Multiples
Luye Pharma Group Ltd Competitors
Luye Pharma Group Ltd Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| CN |
|
Luye Pharma Group Ltd
HKEX:2186
|
10.3B HKD | 1.5 | 23.2 | 4.6 | 7.4 | |
| US |
|
Eli Lilly and Co
NYSE:LLY
|
1.1T USD | 17.6 | 56.9 | 38.1 | 40.9 | |
| US |
|
Johnson & Johnson
NYSE:JNJ
|
564.7B USD | 6 | 21 | 14.7 | 18 | |
| CH |
|
Roche Holding AG
SIX:ROG
|
284B CHF | 4.6 | 30.3 | 12.8 | 14.9 | |
| US |
|
Merck & Co Inc
NYSE:MRK
|
294.9B USD | 4.5 | 16.1 | 10.1 | 11.8 | |
| CH |
|
Novartis AG
SIX:NOVN
|
225.9B CHF | 5.2 | 20.3 | 12.7 | 16.4 | |
| UK |
|
AstraZeneca PLC
LSE:AZN
|
213.4B GBP | 5.1 | 31.7 | 15.1 | 22.1 | |
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
218B USD | 94 | -74.6 | 333.1 | 835.4 | |
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1.3T DKK | 3.9 | 12 | 8.4 | 9.7 | |
| US |
|
Pfizer Inc
NYSE:PFE
|
153.2B USD | 2.4 | 19.6 | 7.3 | 9.8 | |
| US |
|
Bristol-Myers Squibb Co
NYSE:BMY
|
117.3B USD | 2.4 | 19.4 | 6.9 | 9 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
